MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr | ₹10 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹7.26 Cr |
Mar2020 | ₹10 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | -30.98 | |
Mar2023 | ₹15 Cr | 11.78 | |
Mar2022 | ₹14 Cr | 89.48 | |
Mar2021 | ₹7.26 Cr | -28.50 | |
Mar2020 | ₹10 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,118.4 Cr | 1.1% | -26.3% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.1% |
-26.3% |
34.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses